跳至主要内容
临床试验/NCT03528213
NCT03528213已完成2 期

Utility of Sodium Lactate Infusion During Septic Shock: Pilot Study

University Hospital, Lille7 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2019年10月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
59
试验地点
7
主要终点
fluid balance

研究概览

简要总结

ULIS-1 is an open-label pilot study concerning utility of molar sodium lactate in fluid balance in septic shock patients

详细描述

ULIS-1 consists in three arms of treatment during the first 24hrs of septic shock treatment.

  • normal saline
  • sodium lactate 2.5ml/kg in 60min then
  • either 0.25 or 0.5ml/kg/h during 24hrs Main criteria is fluid balance at 48hrs

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Presence of septic shock
  • requiring vascular filling within 12 hours after introduction of Noradrenaline. Septic shock is defined as sepsis with persistent hypotension requiring the administration of vasopressors to maintain RTE > 65mmHg.
  • social insurance

排除标准

  • pregnancy
  • cardiac arrest
  • more than 50ml/kg of fluid loading
  • chronic renal failure with chronic hemodialysis or the investigators estimate a need for renal replacement therapy in the following 24hrs
  • child C or acute liver failure with PT<40% (unless AVK)
  • plasmatic sodium <120 or >145mmol/l
  • metabolic alkalosis with pH>7.45

研究组 & 干预措施

Normal saline

Sham Comparator

at physician discretion

干预措施: Normal saline (Drug)

Sodium lactate light dose

Experimental

bolus 2.5ml/kg lactate 60min then 0.25ml/kg/h during 24hrs

干预措施: Sodium Lactate light dose (Drug)

Sodium lactate high dose

Experimental

bolus 2.5ml/kg lactate 60min then 0.50ml/kg/h during 24hrs

干预措施: Sodium Lactate high dose (Drug)

结局指标

主要结局

fluid balance

时间窗: at 48 hours

fluid balance

次要结局

  • fluid balance at day 7(Day 7)
  • number of patients dead(Day 28)
  • hypokaliemia(Day 2)
  • metabolic alkalosis(day 2)
  • SOFA (Sequential Organ Failure Assessment)(Day 1, Day 2, Day 3, Day 7)
  • death in hospital(Day 90)
  • catecholamines free days(Day 28)
  • death in Intensive Care Unit (ICU)(Day 90)
  • new kidney failure(Day 28)
  • nosocomial infections(day 90)
  • hypernatremia(Day 2)
  • ventilator free days(Day 28)
  • renal replacement therapy free days(Day 28)
  • hemodynamic effects assessed by the PICCO® monitoring system(at 48 hours)

研究者

发起方
University Hospital, Lille
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

Utility of Sodium Lactate Infusion During Septic... | 临床试验